Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29936500 | 0.87 | CYP19A1 (0.57) | GPR3L3MBTL1ATMALDH1A1RAB9A | |
| SCHEMBL6868806 | 0.87 | CYP19A1 (0.57) | GPR3L3MBTL1ATMALDH1A1RAB9A | |
| SCHEMBL1766101 | 0.86 | GABRA1 (0.46) | ALDH1A1RAB9ASLC9A1MEN1KMT2A | |
| SCHEMBL14797947 | 0.85 | GPR3 (0.45) | GPR3L3MBTL1ATMPARP14ALDH1A1 | |
| SCHEMBL2957618 | 0.82 | GPR3 (0.50) | GPR3L3MBTL1ATMPARP14ALDH1A1 | |
| SCHEMBL14798073 | 0.82 | PTPN1 (0.43) | GPR3L3MBTL1ATMPARP14ALDH1A1 | |
| SCHEMBL14325120 | 0.81 | L3MBTL1 (0.53) | GPR3L3MBTL1ATMPARP14ALDH1A1 | |
| SCHEMBL24425722 | 0.81 | ALDH1A1 (0.42) | GPR3L3MBTL1ATMPARP14ALDH1A1 | |
| SCHEMBL21215377 | 0.81 | ATM (0.39) | L3MBTL1ATMCYP19A1CNR1CNR2 | |
| SCHEMBL20858467 | 0.81 | L3MBTL1 (0.39) | L3MBTL1ATMALDH1A1RAB9AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9568460-B2 | Simple method for the detection of sulfur compounds in crude oils and diesel | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2017-02-14 | — | — | US | claimed |
| US-20160061804-A1 | SIMPLE METHOD FOR THE DETECTION OF SULFUR COMPOUNDS IN CRUDE OILS AND DIESEL | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2016-03-03 | — | — | US | claimed |
| CN-117250292-A | Separation and analysis method of heteroatom compounds in petroleum geological sample and application thereof | 中国石油天然气股份有限公司 | 2023-12-19 | — | — | CN | disclosed |
| US-20230371358-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-16 | — | — | US | disclosed |
| US-20230348510-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-02 | — | — | US | disclosed |
| WO-2023206274-A1 | ORGANIC ELECTROLUMINESCENT DIODE AND DISPLAY PANEL | 京东方科技集团股份有限公司 | 2023-11-02 | — | — | WO | disclosed |
| US-20230309381-A1 | AMINE COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-09-28 | — | — | US | disclosed |
| US-20230271988-A1 | METHOD FOR PRODUCING ORGANOMETALLIC NUCLEOPHILE AND REACTION METHOD USING ORGANOMETALLIC NUCLEOPHILE | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2023-08-31 | — | — | US | disclosed |
| US-20230271988-A1 | METHOD FOR PRODUCING ORGANOMETALLIC NUCLEOPHILE AND REACTION METHOD USING ORGANOMETALLIC NUCLEOPHILE | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2023-08-31 | — | — | US | disclosed |
| US-20230247898-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2023-08-03 | — | — | US | disclosed |
| US-11708328-B2 | Organic electroluminescent compound and organic electroluminescent device comprising the same | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. | 2023-07-25 | — | — | US | disclosed |
| US-7238725-B2 | Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them | GLENMARK PHARMACEUTICALS LTD. (IN) | 2007-07-03 | — | — | US | disclosed |
| US-20060178418-A1 | Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders:process for their preparation and pharmaceutical compositions containing them | GLENMARK PHARMACEUTICALS LTD. (IN) | 2006-08-10 | — | — | US | disclosed |
| EP-1554262-A1 | NOVEL TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Glenmark Pharmaceuticals Limited (IN) | 2005-07-20 | — | — | EP | disclosed |
| EP-0970163-B1 | DESULFURIZATION PROCESS FOR REMOVAL OF REFRACTORY ORGANOSULFUR HETEROCYCLES FROM PETROLEUM STREAMS | EXXONMOBIL RES & ENG CO (US) | 2005-04-06 | — | — | EP | disclosed |
| WO-2004037805-A1 | NOVEL TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | GLENMARK PHARMACEUTICALS LTD. (US) | 2004-05-06 | — | — | WO | disclosed |
| EP-0970163-A4 | DESULFURIZATION PROCESS FOR REMOVAL OF REFRACTORY ORGANOSULFUR HETEROCYCLES FROM PETROLEUM STREAMS | EXXON RESEARCH ENGINEERING CO (US) | 2000-05-17 | — | — | EP | disclosed |
| EP-0970163-A1 | DESULFURIZATION PROCESS FOR REMOVAL OF REFRACTORY ORGANOSULFUR HETEROCYCLES FROM PETROLEUM STREAMS | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 2000-01-12 | — | — | EP | disclosed |
| US-5897768-A | CATALYTIC ISOMERIZATION, DISPROPORTIONATION, TRANSALKYLATION | EXXON RESEARCH AND ENGINEERING CO. (US) | 1999-04-27 | — | — | US | disclosed |
| WO-1998038265-A1 | DESULFURIZATION PROCESS FOR REMOVAL OF REFRACTORY ORGANOSULFUR HETEROCYCLES FROM PETROLEUM STREAMS | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1998-09-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230271988-A1 | METHOD FOR PRODUCING ORGANOMETALLIC NUCLEOPHILE AND REACTION METHOD USING ORGANOMETALLIC NUCLEOPHILE | HPD, TALDO1, OGG1 | GPR3 4672/4885L3MBTL1 2878/4885ATM 2060/4885 |
| US-11708328-B2 | Organic electroluminescent compound and organic electroluminescent device comprising the same | ELAVL1, TERT, VDAC2 | GPR3 4587/4885L3MBTL1 239/4885ATM 2151/4885 |
| US-20060178418-A1 | Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders:process for their preparation and pharmaceutical compositions containing them | LTC4S, TSLP, GPR119 | GPR3 728/4885L3MBTL1 4821/4885ATM 3115/4885 |
| US-20230348510-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, OXER1, OXSR1 | GPR3 727/4885L3MBTL1 1969/4885ATM 4232/4885 |
| US-20230247898-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | OPA1, ODC1, TMEM109 | GPR3 4510/4885L3MBTL1 413/4885ATM 2518/4885 |
| US-20230371358-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LIFR, SOD1, ROS1 | GPR3 124/4885L3MBTL1 967/4885ATM 3559/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.